EQ Archived Articles
Equillium (EQ): Navigating the Complexities of Autoimmune Disorder Treatment
Published on March 13, 2025
Equillium, Inc. (EQ): Pioneering Immunology-Driven Therapeutics for Severe Autoimmune Disorders
Published on November 30, 2024
Equillium, Inc. (NASDAQ:EQ): A Promising Biotech Tackling Severe Autoimmune Disorders
Published on September 24, 2024